TransMedics (TMDX) Revenue (2018 - 2026)

TransMedics has reported Revenue for 9 years, with the latest figure at $173.9 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue rose 21.18% year-over-year to $173.9 million; the trailing twelve-month figure through Mar 2026 stood at $635.9 million (up 30.24% YoY), and the FY2025 full-year result was $605.5 million, up 37.13% from the prior year.
• Revenue for Q1 2026 stood at $173.9 million, up from $160.8 million in the prior quarter.
• The five-year high for Revenue was $173.9 million in Q1 2026, with the low at $15.9 million in Q1 2022.
• Average Revenue over 5 years is $91.5 million, with a median of $96.8 million recorded in 2024.
• Year-over-year, Revenue soared 374.47% in 2022 and grew 21.18% in 2026.
• Tracing TMDX's Revenue over 5 years: stood at $31.4 million in 2022, then surged by 158.72% to $81.2 million in 2023, then jumped by 49.83% to $121.6 million in 2024, then surged by 32.18% to $160.8 million in 2025, then climbed by 8.19% to $173.9 million in 2026.
• The last three Revenue figures came in at $173.9 million (Q1 2026), $160.8 million (Q4 2025), and $143.8 million (Q3 2025), per Business Quant data.

Peer Comparison